Company
Sichuan Baili Pharmaceutical Co., Ltd.
Sichuan Baili Pharmaceutical Co., Ltd. has 1 drug tracked on RxWires: 1 in Phase 2/3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| BL-B01D1 | Phase 2/3 | Non-squamous Non-small Cell Lung Cancer |
Latest
No recent events.
Follow Sichuan Baili Pharmaceutical Co., Ltd. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.